More Globe Newswire

View Older Stories View Newer Stories

Mar 27, 2024 08:30AM Li Auto Inc. Announces Put Right Notification for 0.25% Convertible Senior Notes due 2028
Mar 27, 2024 08:30AM Osisko Metals Grants Stock Options
Mar 27, 2024 08:30AM Perma-Fix to Present at the 10th Annual Gabelli & Company Waste Services Symposium in New York City on April 4th
Mar 27, 2024 08:30AM Core Specialty Leads the Way in Innovation with Duck Creek's Cloud-based SaaS Solutions via Microsoft Azure Marketplace
Mar 27, 2024 08:30AM Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce FDA Clearance of the Investigational New Drug Application for Naronapride to Treat Gastroparesis and Subsequent Expansion of the Ongoing Phase
Mar 27, 2024 08:30AM CorMedix Inc. to Present at the Needham Annual Healthcare Conference
Mar 27, 2024 08:30AM Navitas Delivers Grid-Connected Energy with 3.3 kV SiC and Bi-directional GaN ICs at PE International 2024
Mar 27, 2024 08:30AM SRIVARU’s (SVMH) Prana 2.0 Intelligent Battery System Goes Longer and Further: SRIVARU Successfully Completes Road/Performance Testing
Mar 27, 2024 08:30AM Kaival Brands Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update
Mar 27, 2024 08:30AM Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
Mar 27, 2024 08:30AM Epazz, Inc.: Galaxy Batteries, Inc. Unveils Manufacturing Site to Spearhead Solid-State Battery Technology
Mar 27, 2024 08:30AM Odysight.ai Announces 2023 Financial Results and Provides Corporate Update
Mar 27, 2024 08:30AM SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
Mar 27, 2024 08:30AM NEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD CLINICAL COMPOUND, CAN FORCE CANCER CELLS TO GIVE UP THEIR CANCER-CAUSING PROPERTIES
Mar 27, 2024 08:30AM Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
Mar 27, 2024 08:30AM Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors
Mar 27, 2024 08:30AM LM Funding Regains Compliance with Nasdaq Continued Listing Requirements
Mar 27, 2024 08:30AM Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium
Mar 27, 2024 08:30AM Building Supplies Retailer Chooses Bridgeline for AI-Powered Search
Mar 27, 2024 08:30AM Wave Life Sciences to Present at Upcoming Investor Conferences
Mar 27, 2024 08:30AM Dyadic to Attend Industry Events in April
Mar 27, 2024 08:30AM LiveOne (NASDAQ: LVO) Hosts Event Celebrating Women in the Entertainment Industry
Mar 27, 2024 08:30AM Core Specialty Leads the Way in Innovation with Duck Creek's Cloud-based SaaS Solutions via Microsoft Azure Marketplace
Mar 27, 2024 08:30AM Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval in Advanced Recurrent Ovarian Cancer
Mar 27, 2024 08:27AM Bridges Consumer Healthcare Appoints John Speranza as New CEO
Mar 27, 2024 08:16AM Dimensional Fund Advisors Ltd. : Form 8.3 - UK COMMERCIAL PROPERTY REIT - Ordinary Shares
Mar 27, 2024 08:15AM Dimensional Fund Advisors Ltd. : Form 8.3 - TRITAX BIG BOX REIT PLC - Ordinary Shares
Mar 27, 2024 08:13AM Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
Mar 27, 2024 08:12AM Markham Fertility Centre and humm Canada partner to make fertility treatments more accessible
Mar 27, 2024 08:10AM South Korea's Leading Adult Education Company, Fast Campus, Intensifies Its Foray into the US Market with New Business Ventures
Mar 27, 2024 08:10AM South Korea's Leading Adult Education Company, Fast Campus, Intensifies Its Foray into the US Market with New Business Ventures
Mar 27, 2024 08:07AM Aslan Pharmaceuticals to Present at the 2nd Annual H.C. Wainwright Autoimmune and Inflammatory Disease Virtual Conference: Skin Diseases, Conditions and Disorders
Mar 27, 2024 08:06AM Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
Mar 27, 2024 08:05AM Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone
Mar 27, 2024 08:03AM Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
Mar 27, 2024 08:02AM Avicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation
Mar 27, 2024 08:01AM Cumulus Media Announces Extension of Expiration Time in Exchange Offer and Consent Solicitation Relating to 6.750% Senior Secured First-Lien Notes due 2026
Mar 27, 2024 08:00AM UniFirst Announces Financial Results for the Second Quarter of Fiscal 2024
Mar 27, 2024 08:01AM Vizit and Salsify Partner to Deliver AI-Powered Conversion Optimizer Application, Elevating Ecommerce Sales to New Heights
Mar 27, 2024 08:00AM Form 8.3 - [SPIRENT COMMUNICATIONS PLC - 26 03 2024] - (CGAML)
Mar 27, 2024 08:00AM Dynatron Software and NCM Associates Partner On New Fixed Operations Focused 20 Groups
Mar 27, 2024 08:00AM Drilling Underway at Red Mountain Project
Mar 27, 2024 08:00AM ProStar Holdings Announces Closing of First Tranche of Private Placement for Gross Proceeds of US$1 Million
Mar 27, 2024 08:00AM CanStays Rental Alliance to Convene Federal Minister Leblanc, Alberta Minister Schow, and Major Industry Players to Discuss Short-Term Rentals        
Mar 27, 2024 08:00AM Pixalate's February 2024 Global Mobile Publisher Trust Index for Apple App Store and Google Play Store: ESPN Ranks as No. 1 Open Programmatic Ad-Supported App in North America on Apple
Mar 27, 2024 08:00AM SaverOne Signs Milestone OEM Agreement with IVECO
Mar 27, 2024 08:00AM brooqLy Launches Operations in Sub-Saharan Africa with MrExportToAfrica
Mar 27, 2024 08:00AM Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa 
Mar 27, 2024 08:00AM Vocodia Holdings’ AI Technology Featured in USA Today
Mar 27, 2024 08:00AM PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors
View Newer Stories View Older Stories